A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to find out whether CD371-YSNVZ-IL18 CAR T cells are safe, and to look for the highest dose of CD371-YSNVZ-IL18 CAR T cells that cause few or mild side effects in participants.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Rozpoznana ostra białaczka szpikowa z markerem CD371 na komórkach białaczki
- •Dzieci od 1 roku ważące co najmniej 10 kg (dla większości dawek) lub od 12 lat ważące co najmniej 40 kg
- •Dorośli bez ograniczeń wiekowych
- •Pacjenci, którzy nie reagują na standardowe chemioterapię lub u których białaczka powróciła
- •Pacjenci po przeszczepieniu szpiku mogą uczestniczyć jeśli minęło co najmniej 180 dni od zabiegu
- •Brak aktywnej choroby przeszczepowo-powikłanej (GVHD)
Simplified criteria — AI translation
Trial details
- Minimum age
- 1 Year
- Last updated (source)
- October 6, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (7)
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Basking Ridge, United States
Memorial Sloan Kettering Monmouth (Limited protocol activities)
Middletown, United States
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
Montvale, United States
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities)
Commack, United States
Memorial Sloan Kettering Westchester (Limited Protocol Activities)
Harrison, United States
Memorial Sloan Kettering Cancer Center (All protocol activites)
New York, United States
Memorial Sloan Kettering Nassau (Limited Protocol Activites)
Rockville Centre, United States
Trial contact
Mark Geyer, MD
Jae Park, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/7/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.